Motif ID: Zbtb14
Z-value: 1.470
Transcription factors associated with Zbtb14:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Zbtb14 | ENSMUSG00000049672.8 | Zbtb14 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Zbtb14 | mm10_v2_chr17_+_69383768_69383840 | -0.25 | 2.8e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.4 | 22.2 | GO:0032430 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 7.1 | 28.5 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
| 5.3 | 47.9 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 4.7 | 14.2 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 3.2 | 19.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 2.9 | 8.6 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 2.8 | 8.4 | GO:1900673 | olefin metabolic process(GO:1900673) |
| 2.7 | 10.9 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 2.5 | 5.0 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 2.4 | 7.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 2.4 | 7.2 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
| 2.4 | 7.2 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 2.3 | 6.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 2.1 | 6.4 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 2.0 | 6.1 | GO:0030070 | insulin processing(GO:0030070) |
| 2.0 | 14.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 2.0 | 10.0 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 1.9 | 7.7 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 1.9 | 5.7 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 1.9 | 5.7 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.8 | 7.3 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 1.8 | 7.2 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 1.8 | 5.3 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 1.8 | 5.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.7 | 3.3 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 1.6 | 7.9 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 1.5 | 4.5 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
| 1.5 | 4.5 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 1.5 | 4.5 | GO:0072194 | sensory perception of touch(GO:0050975) kidney smooth muscle tissue development(GO:0072194) |
| 1.5 | 9.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 1.5 | 5.9 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
| 1.5 | 4.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 1.4 | 4.2 | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
| 1.4 | 4.2 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
| 1.4 | 5.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
| 1.4 | 15.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 1.3 | 4.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 1.3 | 23.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 1.3 | 17.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 1.2 | 2.5 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 1.2 | 3.6 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) regulation of connective tissue replacement(GO:1905203) |
| 1.2 | 3.6 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.1 | 4.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 1.1 | 1.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
| 1.1 | 4.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 1.1 | 12.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 1.1 | 12.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 1.1 | 6.5 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 1.1 | 9.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 1.1 | 3.2 | GO:2000331 | regulation of terminal button organization(GO:2000331) |
| 1.1 | 12.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.0 | 3.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.0 | 16.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 1.0 | 3.1 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 1.0 | 3.0 | GO:0061744 | motor behavior(GO:0061744) |
| 1.0 | 10.7 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 1.0 | 3.8 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.9 | 11.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.9 | 3.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.9 | 3.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.9 | 3.6 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
| 0.9 | 2.7 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.9 | 2.7 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.9 | 7.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.9 | 7.8 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.9 | 6.0 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.8 | 3.3 | GO:0097298 | regulation of nucleus size(GO:0097298) |
| 0.8 | 5.7 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.8 | 3.2 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.8 | 1.6 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.8 | 3.9 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.8 | 2.3 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.8 | 1.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.8 | 3.8 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
| 0.7 | 0.7 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.7 | 2.2 | GO:0072720 | cellular response to UV-A(GO:0071492) response to dithiothreitol(GO:0072720) |
| 0.7 | 4.3 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.7 | 1.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.7 | 2.1 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.7 | 2.1 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.7 | 2.8 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.7 | 3.5 | GO:0010637 | diet induced thermogenesis(GO:0002024) negative regulation of mitochondrial fusion(GO:0010637) |
| 0.7 | 2.1 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.7 | 2.7 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
| 0.7 | 2.0 | GO:0046671 | regulation of cellular pH reduction(GO:0032847) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.7 | 3.4 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.7 | 18.7 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.7 | 10.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.7 | 3.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.7 | 2.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.6 | 9.0 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.6 | 1.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.6 | 1.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
| 0.6 | 1.2 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
| 0.6 | 2.4 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.6 | 4.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.6 | 5.3 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.6 | 5.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.6 | 5.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.6 | 1.8 | GO:0001757 | somite specification(GO:0001757) |
| 0.6 | 2.3 | GO:1900220 | negative regulation of alkaline phosphatase activity(GO:0010693) semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.6 | 1.8 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.6 | 1.8 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.6 | 1.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.6 | 1.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.6 | 2.8 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.6 | 1.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.5 | 2.2 | GO:0098926 | postsynaptic signal transduction(GO:0098926) |
| 0.5 | 1.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.5 | 6.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.5 | 1.6 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.5 | 2.1 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.5 | 1.6 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.5 | 1.6 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.5 | 2.0 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.5 | 2.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.5 | 1.5 | GO:0035844 | positive regulation of polarized epithelial cell differentiation(GO:0030862) cloaca development(GO:0035844) |
| 0.5 | 2.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.5 | 1.5 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.5 | 3.8 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.5 | 6.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.5 | 4.7 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.5 | 0.9 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
| 0.5 | 0.9 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.5 | 4.6 | GO:0097421 | liver regeneration(GO:0097421) |
| 0.4 | 1.3 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.4 | 4.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.4 | 3.6 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.4 | 2.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.4 | 1.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.4 | 0.4 | GO:0033122 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.4 | 15.0 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.4 | 2.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.4 | 1.7 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.4 | 5.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.4 | 1.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.4 | 4.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.4 | 3.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.4 | 7.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.4 | 2.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.4 | 2.8 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.4 | 3.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.4 | 7.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.4 | 0.8 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.4 | 2.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.4 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.4 | 2.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 0.4 | 1.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.4 | 1.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.4 | 1.5 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.4 | 2.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.4 | 1.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.4 | 9.1 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.4 | 1.5 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.4 | 2.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.4 | 1.8 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.4 | 1.1 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.4 | 3.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.3 | 2.8 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.3 | 5.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 | 1.7 | GO:0019659 | fermentation(GO:0006113) lactate biosynthetic process from pyruvate(GO:0019244) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.3 | 1.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.3 | 7.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.3 | 2.7 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.3 | 1.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 | 7.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.3 | 1.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.3 | 1.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.3 | 4.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.3 | 2.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 | 1.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.3 | 1.4 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.3 | 2.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 | 12.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.3 | 1.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
| 0.3 | 1.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.3 | 3.2 | GO:0001964 | startle response(GO:0001964) |
| 0.3 | 0.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.3 | 1.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.3 | 1.1 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.3 | 5.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.3 | 2.6 | GO:0046959 | habituation(GO:0046959) |
| 0.3 | 1.0 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.3 | 2.0 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.3 | 1.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.3 | 0.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 0.3 | 2.5 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.3 | 0.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 0.2 | 2.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.2 | 0.7 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.2 | 6.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.2 | 1.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.2 | 1.0 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 | 0.7 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 | 1.9 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.2 | 3.9 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.2 | 1.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.2 | 1.2 | GO:0051031 | tRNA transport(GO:0051031) |
| 0.2 | 4.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 | 0.2 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.2 | 2.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.2 | 0.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 | 0.9 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.2 | 2.2 | GO:0034331 | cell junction maintenance(GO:0034331) |
| 0.2 | 1.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 | 4.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.2 | 2.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.2 | 2.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.2 | 0.8 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.2 | 3.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.2 | 3.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
| 0.2 | 8.6 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.2 | 0.6 | GO:0006507 | GPI anchor release(GO:0006507) |
| 0.2 | 0.4 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.2 | 5.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.2 | 1.6 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.2 | 0.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.2 | 2.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 | 0.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.2 | 1.5 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.2 | 0.6 | GO:0019046 | release from viral latency(GO:0019046) regulation of DNA strand elongation(GO:0060382) |
| 0.2 | 1.1 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.2 | 10.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.2 | 0.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.2 | 2.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 | 4.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.2 | 1.1 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.2 | 1.4 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.2 | 1.7 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.2 | 0.3 | GO:0061357 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.2 | 3.9 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.2 | 1.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.2 | 2.7 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
| 0.2 | 0.8 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.2 | 0.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.2 | 1.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.2 | 1.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 4.4 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.2 | 2.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.2 | 0.5 | GO:0090148 | membrane fission(GO:0090148) |
| 0.2 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.2 | 0.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.2 | 0.6 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.2 | 0.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 0.5 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
| 0.2 | 0.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.2 | 2.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.2 | 1.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.2 | 2.1 | GO:0002176 | male germ cell proliferation(GO:0002176) |
| 0.2 | 0.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.2 | 1.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 | 1.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.1 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 | 1.0 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.1 | 4.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.1 | 2.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.1 | 0.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 | 1.6 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 | 1.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
| 0.1 | 1.0 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 1.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 0.7 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.1 | 1.4 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.1 | 0.9 | GO:0001706 | endoderm formation(GO:0001706) |
| 0.1 | 1.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 | 3.2 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 | 0.4 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.1 | 0.5 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
| 0.1 | 0.3 | GO:0035106 | operant conditioning(GO:0035106) |
| 0.1 | 8.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.1 | 2.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.1 | 1.4 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 0.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 0.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
| 0.1 | 1.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 0.5 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 | 3.9 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.1 | 0.5 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.1 | 1.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.1 | 1.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.9 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.1 | 1.6 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.1 | 6.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 0.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 0.3 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.1 | 2.0 | GO:0007616 | long-term memory(GO:0007616) |
| 0.1 | 1.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 | 1.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.1 | 6.8 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.1 | 3.9 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.1 | 0.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.1 | 2.0 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.1 | 0.7 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.1 | 0.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
| 0.1 | 9.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 | 1.5 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.1 | 1.6 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
| 0.1 | 1.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 0.5 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) positive regulation of corticosteroid hormone secretion(GO:2000848) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 | 0.7 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.1 | 1.1 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 | 0.8 | GO:0036065 | fucosylation(GO:0036065) |
| 0.1 | 6.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.1 | 1.4 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.1 | 1.0 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
| 0.1 | 0.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 | 1.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.1 | 0.5 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
| 0.1 | 0.4 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 | 3.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.1 | 1.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.1 | 0.7 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.1 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.1 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 0.3 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 0.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 | 1.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.3 | GO:0060214 | stem cell fate commitment(GO:0048865) stem cell fate specification(GO:0048866) endocardium formation(GO:0060214) |
| 0.1 | 0.4 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 0.2 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 | 5.5 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
| 0.1 | 0.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
| 0.1 | 1.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 1.0 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.1 | 9.1 | GO:0006906 | vesicle fusion(GO:0006906) |
| 0.1 | 0.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.1 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 2.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.1 | 0.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 0.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.1 | 0.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 | 0.4 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.1 | 2.8 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 | 0.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.1 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.1 | 2.2 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 0.1 | 1.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 | 0.9 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 | 0.5 | GO:0031054 | pre-miRNA processing(GO:0031054) |
| 0.1 | 0.2 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 | 0.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 0.1 | GO:0010360 | regulation of anion channel activity(GO:0010359) negative regulation of anion channel activity(GO:0010360) |
| 0.1 | 0.2 | GO:1902302 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) regulation of potassium ion export(GO:1902302) |
| 0.1 | 0.2 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 | 0.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.1 | 0.7 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.1 | 0.5 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.1 | 1.5 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.1 | 1.3 | GO:0002931 | response to ischemia(GO:0002931) |
| 0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 | 1.0 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.1 | 2.3 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
| 0.1 | 2.0 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 | 0.6 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.1 | 0.4 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.1 | 0.2 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.1 | 0.4 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 0.0 | 0.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 1.7 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.0 | 0.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
| 0.0 | 1.8 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.0 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.0 | 0.4 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 0.0 | 0.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 | 1.4 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 | 1.7 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
| 0.0 | 0.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.0 | 0.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.0 | 0.3 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.0 | 0.7 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.0 | 2.9 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.0 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
| 0.0 | 2.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
| 0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 0.1 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 | 0.1 | GO:0048520 | positive regulation of behavior(GO:0048520) |
| 0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.0 | 0.2 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.0 | 0.6 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.0 | 0.6 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
| 0.0 | 0.2 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
| 0.0 | 0.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.0 | 0.2 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) proton-transporting two-sector ATPase complex assembly(GO:0070071) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.0 | 0.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 | 0.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.0 | 0.2 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.0 | 0.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 2.3 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.0 | 0.3 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.0 | 0.1 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.0 | 0.1 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.0 | 1.9 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 1.2 | GO:0098840 | protein transport along microtubule(GO:0098840) |
| 0.0 | 0.5 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.0 | 0.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.0 | 0.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 | 0.4 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) fear response(GO:0042596) |
| 0.0 | 0.3 | GO:0061512 | protein localization to cilium(GO:0061512) |
| 0.0 | 0.1 | GO:0033260 | nuclear DNA replication(GO:0033260) cell cycle DNA replication(GO:0044786) |
| 0.0 | 0.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 | 0.3 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
| 0.0 | 1.4 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
| 0.0 | 0.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.0 | 0.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.0 | 0.1 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.0 | 0.6 | GO:0030641 | regulation of cellular pH(GO:0030641) |
| 0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.0 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
| 0.0 | 0.5 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.3 | 25.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 4.8 | 47.5 | GO:0045298 | tubulin complex(GO:0045298) |
| 3.7 | 22.0 | GO:0008091 | spectrin(GO:0008091) |
| 2.6 | 12.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 2.4 | 7.2 | GO:0072534 | perineuronal net(GO:0072534) |
| 2.1 | 8.4 | GO:0044307 | dendritic branch(GO:0044307) |
| 2.0 | 6.0 | GO:0098830 | presynaptic endosome(GO:0098830) |
| 1.5 | 9.0 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 1.5 | 4.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 1.3 | 25.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 1.3 | 6.5 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
| 1.1 | 4.2 | GO:1902737 | viral replication complex(GO:0019034) dendritic filopodium(GO:1902737) |
| 1.0 | 3.1 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
| 1.0 | 3.1 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
| 1.0 | 3.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 1.0 | 19.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 1.0 | 12.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 1.0 | 2.9 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.9 | 2.8 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
| 0.8 | 5.0 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.8 | 8.0 | GO:0032009 | early phagosome(GO:0032009) |
| 0.8 | 12.3 | GO:0043196 | varicosity(GO:0043196) |
| 0.7 | 3.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
| 0.7 | 2.0 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.6 | 4.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.6 | 1.9 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.6 | 7.9 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.6 | 19.4 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.6 | 3.4 | GO:0045179 | apical cortex(GO:0045179) |
| 0.6 | 7.9 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.5 | 5.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.5 | 1.0 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
| 0.5 | 1.5 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.5 | 2.4 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.5 | 12.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.4 | 0.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.4 | 1.3 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.4 | 5.3 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.4 | 7.4 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.4 | 12.1 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.4 | 1.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.4 | 2.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.4 | 3.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.4 | 13.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.4 | 1.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.4 | 2.9 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.4 | 2.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.4 | 3.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.3 | 5.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.3 | 1.0 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.3 | 2.7 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.3 | 2.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.3 | 2.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.3 | 1.8 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.3 | 20.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.3 | 2.4 | GO:0005883 | neurofilament(GO:0005883) |
| 0.3 | 12.3 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.3 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.3 | 4.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.3 | 4.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.3 | 3.4 | GO:0044754 | autolysosome(GO:0044754) |
| 0.3 | 5.0 | GO:0000145 | exocyst(GO:0000145) |
| 0.3 | 2.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.2 | 2.5 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.2 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.2 | 7.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.2 | 3.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.2 | 5.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.2 | 1.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.2 | 2.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.2 | 14.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.2 | 0.6 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.2 | 2.7 | GO:0046930 | pore complex(GO:0046930) |
| 0.2 | 1.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.2 | 1.0 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.2 | 0.6 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.2 | 2.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.2 | 8.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.2 | 6.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.2 | 5.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.2 | 0.4 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
| 0.2 | 6.1 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.2 | 1.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.2 | 2.1 | GO:0044297 | cell body(GO:0044297) |
| 0.2 | 1.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.2 | 1.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.2 | 1.5 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 1.2 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.2 | 4.0 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.2 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.2 | 43.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.2 | 3.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.2 | 0.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.2 | 1.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 3.4 | GO:0038201 | TOR complex(GO:0038201) |
| 0.2 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.2 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
| 0.2 | 4.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.2 | 0.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.2 | 1.1 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.1 | 2.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 6.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.1 | 4.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.1 | 0.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 0.7 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.1 | 9.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.1 | 7.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 34.2 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 6.9 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.1 | 3.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 33.4 | GO:0014069 | postsynaptic density(GO:0014069) |
| 0.1 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 1.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 0.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.1 | 0.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 0.6 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.1 | 2.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 15.8 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 1.9 | GO:0032589 | neuron projection membrane(GO:0032589) |
| 0.1 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 2.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.1 | 1.7 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 1.5 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 3.3 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.1 | 1.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.1 | 1.3 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 0.7 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.1 | 0.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.1 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 1.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.1 | 1.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 2.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
| 0.1 | 8.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 1.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 0.6 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 1.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 0.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.1 | 10.2 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.1 | 1.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 8.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 13.3 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.1 | 0.4 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 2.1 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.1 | 11.6 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.1 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 4.5 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 1.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 0.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 0.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 41.3 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 2.5 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 0.3 | GO:0097361 | CIA complex(GO:0097361) |
| 0.0 | 0.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.0 | 1.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.0 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 0.4 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.0 | 1.1 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.0 | 1.6 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.0 | 1.0 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.0 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.0 | 0.6 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.0 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.7 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.0 | 0.3 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
| 0.0 | 1.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
| 0.0 | 0.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.6 | GO:0005643 | nuclear pore(GO:0005643) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.8 | 47.5 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 5.1 | 25.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 3.9 | 23.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 3.5 | 17.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 2.7 | 8.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 2.5 | 15.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 2.2 | 11.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 2.1 | 18.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 2.0 | 5.9 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 2.0 | 9.8 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
| 1.6 | 4.9 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 1.5 | 5.9 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 1.4 | 15.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 1.4 | 8.4 | GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 1.4 | 5.6 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 1.3 | 5.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 1.3 | 3.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 1.3 | 3.8 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 1.2 | 3.6 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 1.2 | 7.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 1.2 | 4.8 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 1.2 | 7.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 1.1 | 3.3 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) epinephrine binding(GO:0051379) |
| 1.1 | 6.5 | GO:0002135 | CTP binding(GO:0002135) |
| 1.1 | 14.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 1.1 | 26.9 | GO:0030506 | ankyrin binding(GO:0030506) |
| 1.1 | 6.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 1.1 | 3.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 1.0 | 2.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 1.0 | 24.9 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.9 | 2.7 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.9 | 10.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.8 | 0.8 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.8 | 2.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.8 | 3.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.8 | 5.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.7 | 3.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.7 | 4.4 | GO:0045340 | mercury ion binding(GO:0045340) |
| 0.7 | 2.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.7 | 7.2 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.7 | 2.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.7 | 2.1 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
| 0.7 | 2.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.6 | 5.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.6 | 7.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.6 | 1.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.6 | 4.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.6 | 1.8 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.6 | 3.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.6 | 1.7 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) oncostatin-M receptor activity(GO:0004924) |
| 0.5 | 7.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.5 | 2.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.5 | 4.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.5 | 3.7 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.5 | 1.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.5 | 2.6 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.5 | 2.6 | GO:2001070 | starch binding(GO:2001070) |
| 0.5 | 1.5 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.5 | 1.5 | GO:0034190 | very-low-density lipoprotein particle binding(GO:0034189) apolipoprotein receptor binding(GO:0034190) |
| 0.5 | 8.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.5 | 7.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.5 | 1.9 | GO:0036435 | deubiquitinase activator activity(GO:0035800) K48-linked polyubiquitin binding(GO:0036435) |
| 0.5 | 5.2 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.5 | 4.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.4 | 7.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.4 | 1.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.4 | 3.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.4 | 2.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.4 | 3.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.4 | 2.1 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.4 | 2.5 | GO:0043559 | apolipoprotein A-I binding(GO:0034186) insulin binding(GO:0043559) |
| 0.4 | 21.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.4 | 4.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.4 | 2.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 0.4 | 2.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.4 | 1.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.4 | 1.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.4 | 1.5 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.4 | 2.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.4 | 11.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.4 | 3.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.4 | 8.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.4 | 1.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.4 | 2.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.4 | 3.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.3 | 2.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.3 | 2.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.3 | 2.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.3 | 1.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.3 | 1.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.3 | 2.0 | GO:0043426 | MRF binding(GO:0043426) |
| 0.3 | 15.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.3 | 1.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.3 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.3 | 2.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.3 | 1.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.3 | 1.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.3 | 2.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.3 | 1.8 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 0.3 | 1.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.3 | 11.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.3 | 0.9 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.3 | 5.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.3 | 12.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.3 | 2.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.3 | 3.4 | GO:0023023 | MHC protein complex binding(GO:0023023) |
| 0.3 | 1.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.3 | 2.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.3 | 3.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 1.3 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.3 | 3.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.3 | 1.6 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
| 0.3 | 1.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.3 | 9.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.3 | 1.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.3 | 2.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.3 | 1.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.3 | 0.8 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.3 | 1.5 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.3 | 2.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.2 | 1.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 1.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.2 | 5.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.2 | 2.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.2 | 1.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 1.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.2 | 2.9 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.2 | 2.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.2 | 0.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 2.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.2 | 0.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.2 | 3.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 5.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.2 | 0.9 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.2 | 8.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.2 | 1.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.2 | 1.0 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.2 | 1.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.2 | 5.8 | GO:0005112 | Notch binding(GO:0005112) |
| 0.2 | 16.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.2 | 0.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.2 | 5.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.2 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.2 | 5.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 7.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.2 | 3.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.2 | 3.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 1.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 2.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.2 | 8.8 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.2 | 0.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.2 | 2.4 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 3.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 3.6 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 1.1 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.2 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.2 | 4.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.2 | 1.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 4.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 1.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.1 | 0.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 4.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 0.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 1.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.6 | GO:0070699 | beta-1 adrenergic receptor binding(GO:0031697) activin receptor binding(GO:0070697) type II activin receptor binding(GO:0070699) |
| 0.1 | 36.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 4.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 5.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 1.4 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.1 | 1.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.1 | 0.4 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.1 | 1.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.1 | 1.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.1 | 3.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
| 0.1 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.1 | 6.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.1 | 0.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.1 | 5.0 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 2.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 1.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 9.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 6.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 0.4 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 0.1 | 3.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 10.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.1 | 0.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
| 0.1 | 1.9 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 0.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.1 | 2.4 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
| 0.1 | 1.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.1 | 5.7 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.1 | 4.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.1 | 9.3 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.1 | 3.8 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.1 | 1.0 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 0.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 0.4 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.1 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.1 | 2.7 | GO:0030295 | protein kinase activator activity(GO:0030295) |
| 0.1 | 3.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 1.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.1 | 11.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
| 0.1 | 0.4 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.1 | 2.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 2.8 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.1 | 5.8 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
| 0.1 | 0.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
| 0.1 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 0.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.1 | 2.7 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 1.5 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.1 | 0.3 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 0.1 | 0.7 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
| 0.0 | 1.1 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.0 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.0 | 0.9 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 0.2 | GO:1902282 | C3HC4-type RING finger domain binding(GO:0055131) voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 0.0 | 0.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.0 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 2.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.0 | 0.3 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) uridylate kinase activity(GO:0009041) |
| 0.0 | 0.5 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.0 | 8.9 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 1.6 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.0 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.0 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
| 0.0 | 0.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.0 | 0.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 0.8 | GO:0019903 | protein phosphatase binding(GO:0019903) |
| 0.0 | 1.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.0 | 0.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.0 | 0.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 1.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.0 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.0 | 1.0 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.0 | 0.0 | GO:0070736 | protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) |
| 0.0 | 0.3 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.0 | 0.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.0 | 0.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 1.2 | GO:0015399 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
| 0.0 | 0.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.0 | 0.3 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.0 | 0.3 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 1.0 | GO:0008201 | heparin binding(GO:0008201) |
| 0.0 | 0.3 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.0 | 0.3 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 47.5 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 1.9 | 32.9 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
| 1.0 | 22.2 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.5 | 23.3 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.4 | 6.2 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
| 0.4 | 8.1 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.4 | 2.8 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.3 | 14.8 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.3 | 3.2 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
| 0.3 | 4.7 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
| 0.3 | 6.5 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
| 0.3 | 7.2 | PID_IL12_STAT4_PATHWAY | IL12 signaling mediated by STAT4 |
| 0.3 | 48.5 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
| 0.2 | 7.5 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.2 | 10.3 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.2 | 6.1 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.2 | 5.8 | SIG_BCR_SIGNALING_PATHWAY | Members of the BCR signaling pathway |
| 0.2 | 8.2 | PID_INSULIN_PATHWAY | Insulin Pathway |
| 0.2 | 3.2 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 0.1 | 3.6 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 0.1 | 0.7 | PID_IGF1_PATHWAY | IGF1 pathway |
| 0.1 | 1.5 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 8.6 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 0.1 | 1.5 | PID_ENDOTHELIN_PATHWAY | Endothelins |
| 0.1 | 2.9 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
| 0.1 | 18.5 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 0.8 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
| 0.1 | 2.5 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 15.3 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 3.8 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
| 0.1 | 0.4 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 0.7 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 1.2 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 1.6 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.0 | 0.9 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.8 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 0.9 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
| 0.0 | 1.4 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.5 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.0 | 1.2 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 2.7 | PID_P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.3 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 0.9 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.6 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
| 0.0 | 0.9 | PID_ATR_PATHWAY | ATR signaling pathway |
| 0.0 | 0.6 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 0.0 | 0.3 | PID_IL1_PATHWAY | IL1-mediated signaling events |
| 0.0 | 0.4 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.3 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.2 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 1.1 | PID_P53_REGULATION_PATHWAY | p53 pathway |
| 0.0 | 0.2 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.6 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.1 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.0 | 0.2 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
| 0.0 | 0.5 | ST_INTEGRIN_SIGNALING_PATHWAY | Integrin Signaling Pathway |
| 0.0 | 1.3 | NABA_MATRISOME_ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.1 | 25.6 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 2.1 | 47.3 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 1.6 | 25.3 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 1.3 | 32.5 | REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 1.1 | 12.6 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.8 | 29.0 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.8 | 7.2 | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
| 0.8 | 14.0 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.7 | 17.1 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.7 | 9.8 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.6 | 14.1 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.6 | 19.0 | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.6 | 1.7 | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.5 | 6.4 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.5 | 7.0 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.4 | 10.7 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.4 | 8.8 | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.4 | 4.5 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.3 | 7.1 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.3 | 7.5 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.3 | 3.4 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.3 | 2.8 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.3 | 7.4 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
| 0.3 | 4.9 | REACTOME_SIGNALING_BY_NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.3 | 5.4 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.3 | 3.0 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.3 | 9.5 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.3 | 5.5 | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.3 | 2.1 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | Genes involved in Acyl chain remodelling of PI |
| 0.3 | 8.9 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.3 | 3.4 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.3 | 3.3 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 5.0 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.2 | 2.7 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.2 | 3.6 | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_ | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.2 | 7.6 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
| 0.2 | 5.4 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.2 | 2.2 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 5.5 | REACTOME_KINESINS | Genes involved in Kinesins |
| 0.2 | 1.8 | REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.2 | 2.4 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.2 | 0.8 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.2 | 3.3 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.2 | 3.6 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.2 | 2.4 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.1 | 1.3 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 7.1 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 1.4 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 0.8 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 2.9 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 2.2 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 3.0 | REACTOME_EGFR_DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 2.1 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 3.0 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 7.9 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
| 0.1 | 1.7 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
| 0.1 | 1.1 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.1 | 0.7 | REACTOME_PD1_SIGNALING | Genes involved in PD-1 signaling |
| 0.1 | 1.0 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 0.9 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 1.4 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.1 | 4.1 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 1.0 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 0.7 | REACTOME_SOS_MEDIATED_SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.1 | 1.5 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 4.5 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 1.0 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
| 0.1 | 0.9 | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.1 | 1.4 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 1.1 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 1.3 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 0.4 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.1 | 4.4 | REACTOME_NEURONAL_SYSTEM | Genes involved in Neuronal System |
| 0.1 | 1.2 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 1.1 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 2.2 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.3 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
| 0.0 | 0.6 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 0.3 | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 1.2 | REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
| 0.0 | 2.1 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.7 | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | Genes involved in Regulation of signaling by CBL |
| 0.0 | 1.8 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 2.9 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.3 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.0 | 1.5 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.6 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.4 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.0 | 0.4 | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 0.3 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.0 | 0.6 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 0.3 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
| 0.0 | 0.2 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 0.1 | REACTOME_PYRIMIDINE_CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.0 | 0.2 | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.0 | 0.1 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.0 | 0.2 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
